A detailed history of Family Legacy, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Family Legacy, Inc. holds 17,673 shares of NVO stock, worth $1.81 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
17,673
Previous 16,881 4.69%
Holding current value
$1.81 Million
Previous $2.41 Million 12.66%
% of portfolio
0.71%
Previous 0.87%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $94,303 - $115,172
792 Added 4.69%
17,673 $2.1 Million
Q2 2024

Jul 24, 2024

BUY
$122.71 - $146.91 $21,228 - $25,415
173 Added 1.04%
16,881 $2.41 Million
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $121,000 - $161,065
1,185 Added 7.63%
16,708 $2.15 Million
Q4 2023

Jan 17, 2024

BUY
$87.78 - $105.45 $1.36 Million - $1.64 Million
15,523 New
15,523 $1.61 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Family Legacy, Inc. Portfolio

Follow Family Legacy, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Legacy, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Legacy, Inc. with notifications on news.